Virginia 2025 Regular Session

Virginia House Bill HB1956

Introduced
1/6/25  

Caption

Provider contracts; pharmacies allowed to refuse to fill certain prescriptions.

Impact

The proposed legislation would significantly impact the existing framework of healthcare provider agreements in Virginia. By instituting a cap on the copayment amounts, the bill intends to prevent overcharging and promote transparency in prescription drug pricing. Pharmacies are also granted new rights under this bill, including the ability to inform enrollees about cheaper alternatives and to refuse to fill prescriptions where the reimbursement is below the actual cost of the drug. These provisions aim to empower pharmacies in their interactions with patients and to ensure that enrollees are aware of their options.

Summary

House Bill 1956 aims to amend the Code of Virginia concerning provider contracts between health carriers and pharmacies. The primary focus of the bill is to set limitations on the copayments that enrollees are charged for covered prescription drugs. Specifically, it seeks to ensure that copayments do not exceed the lower of either the regular copayment amount or the cash price of the prescription drug if purchased without insurance. This move is designed to enhance affordability and accessibility for consumers while purchasing medications.

Contention

While the bill seeks to improve patient care by making prescriptions more affordable, there may be contention surrounding its implementation. Concerns could arise from pharmacy benefits managers about the new obligations imposed by this bill, particularly regarding the requirement to disclose certain information to enrollees and the implications for their business models. Additionally, discussions are likely to take place about how these changes could impact the cost structures for pharmacies and health carriers, as well as the potential effects on drug pricing overall.

Companion Bills

No companion bills found.

Similar Bills

NJ S2345

"Patient and Provider Protection Act."

NJ A1502

"Patient and Provider Protection Act."

TX SB493

Relating to protection of certain disclosures and communications by pharmacists and pharmacies regarding prescription drug benefits.

CA AB577

Health care coverage: antisteering.

NV SB389

Revises provisions relating to the administration of pharmacy benefits under Medicaid and certain other health plans. (BDR 38-240)

NJ A5020

Prohibits pharmacy benefit manager from using spread pricing as model of prescription drug pricing; requires transparency in provision of pharmacy benefits management services.

PA HB2270

In preliminary provisions, further providing for definitions; and, in pharmacy benefits manager contracts, providing for State pharmacy benefits manager.

PA SB1186

In preliminary provisions, further providing for definitions; and, in pharmacy benefits manager contracts, providing for State pharmacy benefits manager.